On Day 4 of JPM, a chat with Regeneron’s George Yancopoulos, an IPO forecast, and all eyes on J&J Plus: Makary touts new FDA voucher program, despite criticism

https://www.statnews.com/2026/01/15/jpm-2026-day-4-top-stories-regeneron-fda-ipos-jnj/ By Allison DeAngelis, Matthew Herper, Adam Feuerstein, and Elaine ChenJan. 15, 2026